Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 401–500 of 1,043
Ubiquitin–proteasome system and Parkinson's disease
Olanow, C. W., & McNaught, K. S. P. (2006) · Movement Disorders · doi:10.1002/mds.21013 · Cited by 212
Advancement in the modelling and therapeutics of Parkinson’s disease
Rai, S. N., & Singh, P. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101752 · Cited by 213
Haynes, C. M., Fiorese, C. J., & Lin, Y.-F. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.02.002 · Cited by 211
A Ubl/ubiquitin switch in the activation of Parkin
Sauvé, V., Lilov, A., Seirafi, M., Vranas, M., Rasool, S., Kozlov, G., Sprules, T., Wang, J., Trempe, J., & Gehring, K. (2015) · The EMBO Journal · doi:10.15252/embj.201592237 · Cited by 212
Iorio, R., Celenza, G., & Petricca, S. (2021) · Cells · doi:10.3390/cells11010030 · Cited by 209
Drosophila in the Study of Neurodegenerative Disease
Marsh, J. L., & Thompson, L. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.025 · Cited by 212
Mitophagy: A Complex Mechanism of Mitochondrial Removal
Novak, I. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4407 · Cited by 211
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 211
The pathogenesis of cell death in Parkinson's disease – 2007
Olanow, C. W. (2007) · Movement Disorders · doi:10.1002/mds.21675 · Cited by 211
Kotiadis, V. N., Duchen, M. R., & Osellame, L. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.041 · Cited by 210
“familial Parkinson's disease [105,106].”
Nakamura, K., Nemani, V. M., Wallender, E. K., Kaehlcke, K., Ott, M., & Edwards, R. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-08.2008 · Cited by 210
Effects of curcumin on mitochondria in neurodegenerative diseases
Bagheri, H., Ghasemi, F., Barreto, G. E., Rafiee, R., Sathyapalan, T., & Sahebkar, A. (2020) · BioFactors · doi:10.1002/biof.1566 · Cited by 209
Gan, Z. Y., Callegari, S., Cobbold, S. A., Cotton, T. R., Mlodzianoski, M. J., Schubert, A. F., Geoghegan, N. D., Rogers, K. L., Leis, A., Dewson, G., et al. (2022) · Nature · doi:10.1038/s41586-021-04340-2 · Cited by 206
The genetics of Parkinson's syndromes: a critical review
Hardy, J., Lewis, P., Revesz, T., Lees, A., & Paisan-Ruiz, C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.03.008 · Cited by 209
Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation
Iguchi, M., Kujuro, Y., Okatsu, K., Koyano, F., Kosako, H., Kimura, M., Suzuki, N., Uchiyama, S., Tanaka, K., & Matsuda, N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467530 · Cited by 209
“PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism.”
BackgroundInfluentialCastelli, V., Benedetti, E., Antonosante, A., Catanesi, M., Pitari, G., Ippoliti, R., Cimini, A., & d’Angelo, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00132 · Cited by 208
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity
Ko, H. S., Bailey, R., Smith, W. W., Liu, Z., Shin, J.-H., Lee, Y.-I., Zhang, Y.-J., Jiang, H., Ross, C. A., Moore, D. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810123106 · Cited by 208
Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208
Impaired dopamine release in Parkinson’s disease
Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J., & Wade-Martins, R. (2023) · Brain · doi:10.1093/brain/awad064 · Cited by 207
“PINK1 is a mitochondrial protein kinase in which loss-of-function mutations are the second most frequent known cause of autosomal recessive Parkinson’s disease.(96) This protein regulates the activity of parkin, affects mitochondrial stability and modulates mito-”
BackgroundCui, M., Tang, X., Christian, W. V., Yoon, Y., & Tieu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066662 · Cited by 207
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 207
Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases
Martin, L. J. (2010) · Pharmaceuticals · doi:10.3390/ph3040839 · Cited by 206
ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons
Joselin, A. P., Hewitt, S. J., Callaghan, S. M., Kim, R. H., Chung, Y.-H., Mak, T. W., Shen, J., Slack, R. S., & Park, D. S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds325 · Cited by 206
PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival
Lee, Y., Stevens, D. A., Kang, S.-U., Jiang, H., Lee, Y.-I., Ko, H. S., Scarffe, L. A., Umanah, G. E., Kang, H., Ham, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.090 · Cited by 206
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
Chung, S. Y., Kishinevsky, S., Mazzulli, J. R., Graziotto, J., Mrejeru, A., Mosharov, E. V., Puspita, L., Valiulahi, P., Sulzer, D., Milner, T. A., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.012 · Cited by 205
“Patients with recessively inherited PARK2/Parkin (Kitada et al., 1998) and PTEN-induced putative kinase 1 (PINK1) (Valente et al., 2004) mutations represent one of several monogenic forms of PD. Recent studies demonstrated the involvement of both Parkin and PINK1 in mitochondrial function (Imaizumi…”
BackgroundPARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease
Martín-Maestro, P., Gargini, R., Perry, G., Avila, J., & García-Escudero, V. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv616 · Cited by 184
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 203
Self-citationMitochondrial dysfunction in Parkinson’s disease
Hu, Q., & Wang, G. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0060-6 · Cited by 196
Hepatitis C Virus Induces the Mitochondrial Translocation of Parkin and Subsequent Mitophagy
Kim, S.-J., Syed, G. H., & Siddiqui, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003285 · Cited by 201
Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200
Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications
Banerjee, R., Beal, M. F., & Thomas, B. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.09.001 · Cited by 199
Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
Rogaeva, E., Johnson, J., Lang, A. E., Gulick, C., Gwinn-Hardy, K., Kawarai, T., Sato, C., Morgan, A., Werner, J., Nussbaum, R., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1898 · Cited by 199
Self-citationDepletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance
Heeman, B., Van den Haute, C., Aelvoet, S.-A., Valsecchi, F., Rodenburg, R. J., Reumers, V., Debyser, Z., Callewaert, G., Koopman, W. J. H., Willems, P. H. G. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.078303 · Cited by 198
Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
“In particular, the identification of mutations in PINK1 has strongly implicated mitochondrial dysfunction in the pathogenesis of PD [7].”
Antioxidants protect PINK1 -dependent dopaminergic neurons in Drosophila
Wang, D., Qian, L., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., & Zhang, Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604661103 · Cited by 197
Williams, D. R., Hadeed, A., al‐Din, A. S. N., Wreikat, A., & Lees, A. J. (2005) · Movement Disorders · doi:10.1002/mds.20511 · Cited by 197
DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease
Olgiati, S., Quadri, M., Fang, M., Rood, J. P. M. A., Saute, J. A., Chien, H. F., Bouwkamp, C. G., Graafland, J., Minneboo, M., Breedveld, G. J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24553 · Cited by 197
Mitochondrial heterogeneity and homeostasis through the lens of a neuron
Pekkurnaz, G., & Wang, X. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00594-w · Cited by 197
Neurodegenerative Disease and the NLRP3 Inflammasome
Holbrook, J. A., Jarosz-Griffiths, H. H., Caseley, E., Lara-Reyna, S., Poulter, J. A., Williams-Gray, C. H., Peckham, D., & McDermott, M. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 194
Progress in Parkinson's disease—Where do we stand?
Toulouse, A., & Sullivan, A. M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.05.003 · Cited by 195
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 194
Sämann, J., Hegermann, J., von Gromoff, E., Eimer, S., Baumeister, R., & Schmidt, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808255200 · Cited by 193
Mitochondria as a central sensor for axonal degenerative stimuli
Court, F. A., & Coleman, M. P. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.001 · Cited by 194
Franco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 194
Mechanism of parkin activation by phosphorylation
Sauvé, V., Sung, G., Soya, N., Kozlov, G., Blaimschein, N., Miotto, L. S., Trempe, J.-F., Lukacs, G. L., & Gehring, K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0088-7 · Cited by 191
Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy
Tanaka, K., & Matsuda, N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.012 · Cited by 191
Genetics of Parkinsonʼs disease
Gasser, T. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000170951.08924.3d · Cited by 192
Syndromic parkinsonism and dementia associated with OPA 1 missense mutations
Carelli, V., Musumeci, O., Caporali, L., Zanna, C., La Morgia, C., Del Dotto, V., Porcelli, A. M., Rugolo, M., Valentino, M. L., Iommarini, L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24410 · Cited by 191
Self-citationPink1 regulates the oxidative phosphorylation machinery via mitochondrial fission
Liu, W., Acín-Peréz, R., Geghman, K. D., Manfredi, G., Lu, B., & Li, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107332108 · Cited by 190
Phosphorylation of Mitochondrial Polyubiquitin by PINK1 Promotes Parkin Mitochondrial Tethering
Shiba-Fukushima, K., Arano, T., Matsumoto, G., Inoshita, T., Yoshida, S., Ishihama, Y., Ryu, K.-Y., Nukina, N., Hattori, N., & Imai, Y. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004861 · Cited by 190
FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
Kabashi, E., Bercier, V., Lissouba, A., Liao, M., Brustein, E., Rouleau, G. A., & Drapeau, P. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002214 · Cited by 190
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carrì, M. T., & Barone, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm080 · Cited by 190
Molecular genetics of Parkinson’s disease: Contributions and global trends
Funayama, M., Nishioka, K., Li, Y., & Hattori, N. (2023) · Journal of Human Genetics · doi:10.1038/s10038-022-01058-5 · Cited by 189
Koentjoro, B., Park, J.-S., & Sue, C. M. (2017) · Scientific Reports · doi:10.1038/srep44373 · Cited by 189
Cell death: protein misfolding and neurodegenerative diseases
Nakamura, T., & Lipton, S. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0301-y · Cited by 189
Whitworth, A. J., Lee, J. R., Ho, V. M.-W., Flick, R., Chowdhury, R., & McQuibban, G. A. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000109 · Cited by 189
Ordureau, A., Paulo, J. A., Zhang, W., Ahfeldt, T., Zhang, J., Cohn, E. F., Hou, Z., Heo, J.-M., Rubin, L. L., Sidhu, S. S., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.012 · Cited by 188
Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function
Yi, J. J., & Ehlers, M. D. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.4 · Cited by 224
Akundi, R. S., Huang, Z., Eason, J., Pandya, J. D., Zhi, L., Cass, W. A., Sullivan, P. G., & Büeler, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016038 · Cited by 187
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
TRAP-1, the mitochondrial Hsp90
Altieri, D. C., Stein, G. S., Lian, J. B., & Languino, L. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.08.007 · Cited by 186
Mitochondrial DNA damage and repair in neurodegenerative disorders
Yang, J.-L., Weissman, L., Bohr, V. A., & Mattson, M. P. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.03.012 · Cited by 186
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 184
Mitochondrial function in development and disease
Rossmann, M. P., Dubois, S. M., Agarwal, S., & Zon, L. I. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048912 · Cited by 184
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
Zharikov, A. D., Cannon, J. R., Tapias, V., Bai, Q., Horowitz, M. P., Shah, V., El Ayadi, A., Hastings, T. G., Greenamyre, J. T., & Burton, E. A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci64502 · Cited by 186
Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
Cole, N. B., DiEuliis, D., Leo, P., Mitchell, D. C., & Nussbaum, R. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.012 · Cited by 185
Self-citationPatel, A. S., Song, J. W., Chu, S. G., Mizumura, K., Osorio, J. C., Shi, Y., El-Chemaly, S., Lee, C. G., Rosas, I. O., Elias, J. A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121246 · Cited by 185
SQSTM1/p62: a potential target for neurodegenerative disease
Ma, S., Attarwala, I. Y., & Xie, X.-Q. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00516 · Cited by 185
Role of nitric oxide in Parkinson's disease
Zhang, L., Dawson, V. L., & Dawson, T. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.007 · Cited by 184
Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities
Shinbo, Y., Niki, T., Taira, T., Ooe, H., Takahashi-Niki, K., Maita, C., Seino, C., Iguchi-Ariga, S. M. M., & Ariga, H. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401704 · Cited by 184
Distribution of PINK1 and LRRK2 in rat and mouse brain
Taymans, J., Van den Haute, C., & Baekelandt, V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03919.x · Cited by 184
Pathogenesis of nigral cell death in Parkinson's disease
Przedborski, S. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.012 · Cited by 183
Sha, D., Chin, L.-S., & Li, L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 184
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M.-F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 183
Emerging role of mitophagy in human diseases and physiology
Um, J.-H., & Yun, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.6.056 · Cited by 183
Structure of PINK1 in complex with its substrate ubiquitin
Schubert, A. F., Gladkova, C., Pardon, E., Wagstaff, J. L., Freund, S. M. V., Steyaert, J., Maslen, S. L., & Komander, D. (2017) · Nature · doi:10.1038/nature24645 · Cited by 182
Wu, W., Xu, H., Wang, Z., Mao, Y., Yuan, L., Luo, W., Cui, Z., Cui, T., Wang, X. L., & Shen, Y. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132499 · Cited by 182
Mitochondrial Fission in Human Diseases
Serasinghe, M. N., & Chipuk, J. E. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_38 · Cited by 182
The PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
Park, J., Lee, G., & Chung, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.086 · Cited by 180
NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions
Murata, H., Takamatsu, H., Liu, S., Kataoka, K., Huh, N.-H., & Sakaguchi, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142438 · Cited by 180
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Larsen, S. B., Hanss, Z., & Krüger, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2768-8 · Cited by 181
“Indeed, a variety of loss of function mutations of PINK1 (PARK6, OMIM: 605,909) and Parkin (PRKN/PARK2, OMIM: 602,544) have been found in juvenile PD patients (Valente et al. 2004; Kitada et al. 1998).”
BackgroundAutophagy and mitophagy in ALS
Evans, C. S., & Holzbaur, E. L. F. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.005 · Cited by 181
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
Ibáñez, P., Lesage, S., Lohmann, E., Thobois, S., Michele, G. D., Borg, M., Agid, Y., Dürr, A., & Brice, A. (2006) · Brain · doi:10.1093/brain/awl005 · Cited by 182
The role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180
Phosphoproteomic screening identifies Rab GTP ases as novel downstream targets of PINK 1
Lai, Y., Kondapalli, C., Lehneck, R., Procter, J. B., Dill, B. D., Woodroof, H. I., Gourlay, R., Peggie, M., Macartney, T. J., Corti, O., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591593 · Cited by 179
Self-citationInden, M., Taira, T., Kitamura, Y., Yanagida, T., Tsuchiya, D., Takata, K., Yanagisawa, D., Nishimura, K., Taniguchi, T., Kiso, Y., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.004 · Cited by 180
Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish
Anichtchik, O., Diekmann, H., Fleming, A., Roach, A., Goldsmith, P., & Rubinsztein, D. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0979-08.2008 · Cited by 178
Pedrola, L., Espert, A., Wu, X., Claramunt, R., Shy, M. E., & Palau, F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi121 · Cited by 179
Genetics and genomics of Parkinson’s disease
Lin, M. K., & Farrer, M. J. (2014) · Genome Medicine · doi:10.1186/gm566 · Cited by 179
Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment
Esmaeili, Y., Yarjanli, Z., Pakniya, F., Bidram, E., Łos, M. J., Eshraghi, M., Klionsky, D. J., Ghavami, S., & Zarrabi, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.001 · Cited by 179
Hallmarks of a new era in mitochondrial biochemistry
Pagliarini, D. J., & Rutter, J. (2013) · Genes & Development · doi:10.1101/gad.229724.113 · Cited by 179
Signal transduction to the permeability transition pore
Rasola, A., Sciacovelli, M., Pantic, B., & Bernardi, P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.022 · Cited by 178
Kostic, M., Ludtmann, M. H. R., Bading, H., Hershfinkel, M., Steer, E., Chu, C. T., Abramov, A. Y., & Sekler, I. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.079 · Cited by 177
LRRK2 gene in Parkinson disease: Mutation analysis and case control association study
Paisán-Ruíz, C., Lang, A. E., Kawarai, T., Sato, C., Salehi-Rad, S., Fisman, G. K., Al-Khairallah, T., St George-Hyslop, P., Singleton, A., & Rogaeva, E. (2005) · Neurology · doi:10.1212/01.wnl.0000167552.79769.b3 · Cited by 178
Dystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176
Mitochondrial quality control in human health and disease
Liu, B.-H., Xu, C.-Z., Liu, Y., Lu, Z.-L., Fu, T.-L., Li, G.-R., Deng, Y., Luo, G.-Q., Ding, S., Li, N., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00536-5 · Cited by 171
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 178
Mandemakers, W., Morais, V. A., & De Strooper, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.03443 · Cited by 176
Sandebring, A., Thomas, K. J., Beilina, A., van der Brug, M., Cleland, M. M., Ahmad, R., Miller, D. W., Zambrano, I., Cowburn, R. F., Behbahani, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005701 · Cited by 176
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.